nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AHR—liver cancer	0.505	0.763	CbGaD
Flutamide—CYP1A1—liver cancer	0.156	0.237	CbGaD
Flutamide—CYP1B1—Doxorubicin—liver cancer	0.0789	0.42	CbGbCtD
Flutamide—CYP3A5—Sorafenib—liver cancer	0.0343	0.182	CbGbCtD
Flutamide—CYP2C19—Sorafenib—liver cancer	0.0276	0.147	CbGbCtD
Flutamide—CYP1A2—Sorafenib—liver cancer	0.0255	0.136	CbGbCtD
Flutamide—CYP3A4—Sorafenib—liver cancer	0.0134	0.0711	CbGbCtD
Flutamide—CYP3A4—Doxorubicin—liver cancer	0.0081	0.0432	CbGbCtD
Flutamide—Carcinoma—Sorafenib—liver cancer	0.0037	0.0653	CcSEcCtD
Flutamide—Metastatic neoplasm—Epirubicin—liver cancer	0.00216	0.038	CcSEcCtD
Flutamide—Metastatic neoplasm—Doxorubicin—liver cancer	0.00199	0.0352	CcSEcCtD
Flutamide—Proctitis—Epirubicin—liver cancer	0.00169	0.0299	CcSEcCtD
Flutamide—Interstitial lung disease—Sorafenib—liver cancer	0.00158	0.0279	CcSEcCtD
Flutamide—Proctitis—Doxorubicin—liver cancer	0.00157	0.0276	CcSEcCtD
Flutamide—Neoplasm malignant—Sorafenib—liver cancer	0.00131	0.0231	CcSEcCtD
Flutamide—Bullous eruption—Epirubicin—liver cancer	0.00105	0.0184	CcSEcCtD
Flutamide—Neoplasm—Sorafenib—liver cancer	0.00101	0.0178	CcSEcCtD
Flutamide—Gynaecomastia—Sorafenib—liver cancer	0.001	0.0176	CcSEcCtD
Flutamide—Laboratory test abnormal—Epirubicin—liver cancer	0.00099	0.0174	CcSEcCtD
Flutamide—Bullous eruption—Doxorubicin—liver cancer	0.000968	0.0171	CcSEcCtD
Flutamide—Laboratory test abnormal—Doxorubicin—liver cancer	0.000916	0.0161	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.000731	0.0129	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.000731	0.0129	CcSEcCtD
Flutamide—Transaminases increased—Epirubicin—liver cancer	0.000679	0.012	CcSEcCtD
Flutamide—Erectile dysfunction—Sorafenib—liver cancer	0.000646	0.0114	CcSEcCtD
Flutamide—Transaminases increased—Doxorubicin—liver cancer	0.000629	0.0111	CcSEcCtD
Flutamide—Jaundice—Sorafenib—liver cancer	0.00061	0.0108	CcSEcCtD
Flutamide—Herpes zoster—Epirubicin—liver cancer	0.000549	0.00968	CcSEcCtD
Flutamide—Herpes zoster—Doxorubicin—liver cancer	0.000508	0.00896	CcSEcCtD
Flutamide—Liver injury—Epirubicin—liver cancer	0.000491	0.00866	CcSEcCtD
Flutamide—Erythema—Sorafenib—liver cancer	0.000489	0.00862	CcSEcCtD
Flutamide—Neoplasm malignant—Epirubicin—liver cancer	0.000484	0.00854	CcSEcCtD
Flutamide—Jaundice cholestatic—Epirubicin—liver cancer	0.00047	0.0083	CcSEcCtD
Flutamide—Rectal haemorrhage—Epirubicin—liver cancer	0.000458	0.00807	CcSEcCtD
Flutamide—Liver injury—Doxorubicin—liver cancer	0.000455	0.00801	CcSEcCtD
Flutamide—Anaemia—Sorafenib—liver cancer	0.000452	0.00797	CcSEcCtD
Flutamide—Neoplasm malignant—Doxorubicin—liver cancer	0.000448	0.0079	CcSEcCtD
Flutamide—Leukopenia—Sorafenib—liver cancer	0.000438	0.00772	CcSEcCtD
Flutamide—Ulcer—Epirubicin—liver cancer	0.000437	0.00771	CcSEcCtD
Flutamide—Jaundice cholestatic—Doxorubicin—liver cancer	0.000435	0.00768	CcSEcCtD
Flutamide—Rectal haemorrhage—Doxorubicin—liver cancer	0.000423	0.00747	CcSEcCtD
Flutamide—Hypertension—Sorafenib—liver cancer	0.000422	0.00744	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000413	0.00729	CcSEcCtD
Flutamide—Pulmonary embolism—Epirubicin—liver cancer	0.000413	0.00729	CcSEcCtD
Flutamide—Ulcer—Doxorubicin—liver cancer	0.000404	0.00713	CcSEcCtD
Flutamide—Cystitis noninfective—Epirubicin—liver cancer	0.000404	0.00712	CcSEcCtD
Flutamide—Cystitis—Epirubicin—liver cancer	0.000399	0.00704	CcSEcCtD
Flutamide—Thrombocytopenia—Sorafenib—liver cancer	0.000391	0.00689	CcSEcCtD
Flutamide—Blood urea increased—Epirubicin—liver cancer	0.00039	0.00688	CcSEcCtD
Flutamide—Skin disorder—Sorafenib—liver cancer	0.000388	0.00683	CcSEcCtD
Flutamide—Pulmonary embolism—Doxorubicin—liver cancer	0.000382	0.00674	CcSEcCtD
Flutamide—Anorexia—Sorafenib—liver cancer	0.00038	0.00671	CcSEcCtD
Flutamide—Ecchymosis—Epirubicin—liver cancer	0.000374	0.00659	CcSEcCtD
Flutamide—Bladder pain—Epirubicin—liver cancer	0.000374	0.00659	CcSEcCtD
Flutamide—Neoplasm—Epirubicin—liver cancer	0.000374	0.00659	CcSEcCtD
Flutamide—Cystitis noninfective—Doxorubicin—liver cancer	0.000374	0.00659	CcSEcCtD
Flutamide—Cystitis—Doxorubicin—liver cancer	0.000369	0.00651	CcSEcCtD
Flutamide—Blood urea increased—Doxorubicin—liver cancer	0.000361	0.00637	CcSEcCtD
Flutamide—Decreased appetite—Sorafenib—liver cancer	0.000347	0.00612	CcSEcCtD
Flutamide—Bladder pain—Doxorubicin—liver cancer	0.000346	0.0061	CcSEcCtD
Flutamide—Neoplasm—Doxorubicin—liver cancer	0.000346	0.0061	CcSEcCtD
Flutamide—Ecchymosis—Doxorubicin—liver cancer	0.000346	0.0061	CcSEcCtD
Flutamide—Diabetes mellitus—Epirubicin—liver cancer	0.000345	0.00608	CcSEcCtD
Flutamide—Fatigue—Sorafenib—liver cancer	0.000344	0.00607	CcSEcCtD
Flutamide—Constipation—Sorafenib—liver cancer	0.000341	0.00602	CcSEcCtD
Flutamide—Hot flush—Epirubicin—liver cancer	0.000321	0.00566	CcSEcCtD
Flutamide—Increased appetite—Epirubicin—liver cancer	0.000319	0.00563	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—liver cancer	0.000319	0.00563	CcSEcCtD
Flutamide—Menopausal symptoms—Epirubicin—liver cancer	0.000318	0.00561	CcSEcCtD
Flutamide—Dermatitis bullous—Epirubicin—liver cancer	0.000314	0.00554	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—liver cancer	0.000297	0.00523	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—liver cancer	0.000295	0.00521	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—liver cancer	0.000294	0.00519	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—liver cancer	0.00029	0.00512	CcSEcCtD
Flutamide—Asthenia—Sorafenib—liver cancer	0.000286	0.00505	CcSEcCtD
Flutamide—Pruritus—Sorafenib—liver cancer	0.000282	0.00498	CcSEcCtD
Flutamide—Diarrhoea—Sorafenib—liver cancer	0.000273	0.00481	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00027	0.00476	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00027	0.00476	CcSEcCtD
Flutamide—Dizziness—Sorafenib—liver cancer	0.000264	0.00465	CcSEcCtD
Flutamide—Vomiting—Sorafenib—liver cancer	0.000254	0.00447	CcSEcCtD
Flutamide—Rash—Sorafenib—liver cancer	0.000252	0.00444	CcSEcCtD
Flutamide—Dermatitis—Sorafenib—liver cancer	0.000251	0.00443	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00025	0.00441	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00025	0.00441	CcSEcCtD
Flutamide—Headache—Sorafenib—liver cancer	0.00025	0.00441	CcSEcCtD
Flutamide—Nausea—Sorafenib—liver cancer	0.000237	0.00418	CcSEcCtD
Flutamide—Photosensitivity reaction—Epirubicin—liver cancer	0.000237	0.00417	CcSEcCtD
Flutamide—Hyperglycaemia—Epirubicin—liver cancer	0.000234	0.00413	CcSEcCtD
Flutamide—Drowsiness—Epirubicin—liver cancer	0.000231	0.00408	CcSEcCtD
Flutamide—Jaundice—Epirubicin—liver cancer	0.000225	0.00397	CcSEcCtD
Flutamide—Haematuria—Epirubicin—liver cancer	0.00022	0.00389	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—liver cancer	0.000219	0.00386	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—liver cancer	0.000216	0.00382	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—liver cancer	0.000214	0.00377	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—liver cancer	0.000209	0.00368	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—liver cancer	0.000208	0.00366	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—liver cancer	0.000204	0.00361	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—liver cancer	0.000204	0.0036	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—liver cancer	0.000192	0.00339	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—liver cancer	0.000189	0.00334	CcSEcCtD
Flutamide—Erythema—Epirubicin—liver cancer	0.000181	0.00319	CcSEcCtD
Flutamide—Tension—Epirubicin—liver cancer	0.000177	0.00313	CcSEcCtD
Flutamide—Nervousness—Epirubicin—liver cancer	0.000175	0.00309	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—liver cancer	0.000168	0.00296	CcSEcCtD
Flutamide—Erythema—Doxorubicin—liver cancer	0.000167	0.00295	CcSEcCtD
Flutamide—Anaemia—Epirubicin—liver cancer	0.000167	0.00295	CcSEcCtD
Flutamide—Tension—Doxorubicin—liver cancer	0.000164	0.00289	CcSEcCtD
Flutamide—Malaise—Epirubicin—liver cancer	0.000163	0.00287	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—liver cancer	0.000162	0.00286	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—liver cancer	0.000162	0.00285	CcSEcCtD
Flutamide—Hypertension—Epirubicin—liver cancer	0.000156	0.00275	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—liver cancer	0.000155	0.00274	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—liver cancer	0.000155	0.00272	CcSEcCtD
Flutamide—Anxiety—Epirubicin—liver cancer	0.000153	0.0027	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000153	0.00269	CcSEcCtD
Flutamide—Discomfort—Epirubicin—liver cancer	0.000152	0.00268	CcSEcCtD
Flutamide—Malaise—Doxorubicin—liver cancer	0.000151	0.00266	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—liver cancer	0.00015	0.00264	CcSEcCtD
Flutamide—Confusional state—Epirubicin—liver cancer	0.000149	0.00262	CcSEcCtD
Flutamide—Oedema—Epirubicin—liver cancer	0.000147	0.0026	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—liver cancer	0.000144	0.00255	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—liver cancer	0.000144	0.00255	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—liver cancer	0.000143	0.00253	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—liver cancer	0.000142	0.0025	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000141	0.00249	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—liver cancer	0.000141	0.00248	CcSEcCtD
Flutamide—Anorexia—Epirubicin—liver cancer	0.000141	0.00248	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—liver cancer	0.000138	0.00243	CcSEcCtD
Flutamide—Oedema—Doxorubicin—liver cancer	0.000136	0.00241	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—liver cancer	0.000134	0.00236	CcSEcCtD
Flutamide—Insomnia—Epirubicin—liver cancer	0.000133	0.00235	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—liver cancer	0.000133	0.00234	CcSEcCtD
Flutamide—Somnolence—Epirubicin—liver cancer	0.000131	0.00231	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—liver cancer	0.00013	0.00229	CcSEcCtD
Flutamide—Decreased appetite—Epirubicin—liver cancer	0.000128	0.00226	CcSEcCtD
Flutamide—Fatigue—Epirubicin—liver cancer	0.000127	0.00224	CcSEcCtD
Flutamide—Constipation—Epirubicin—liver cancer	0.000126	0.00222	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—liver cancer	0.000123	0.00218	CcSEcCtD
Flutamide—Feeling abnormal—Epirubicin—liver cancer	0.000122	0.00214	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—liver cancer	0.000121	0.00214	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—liver cancer	0.000119	0.00209	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—liver cancer	0.000118	0.00207	CcSEcCtD
Flutamide—Constipation—Doxorubicin—liver cancer	0.000117	0.00206	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—liver cancer	0.000112	0.00198	CcSEcCtD
Flutamide—Asthenia—Epirubicin—liver cancer	0.000106	0.00187	CcSEcCtD
Flutamide—Pruritus—Epirubicin—liver cancer	0.000104	0.00184	CcSEcCtD
Flutamide—Diarrhoea—Epirubicin—liver cancer	0.000101	0.00178	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—liver cancer	9.79e-05	0.00173	CcSEcCtD
Flutamide—Dizziness—Epirubicin—liver cancer	9.75e-05	0.00172	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—liver cancer	9.65e-05	0.0017	CcSEcCtD
Flutamide—Vomiting—Epirubicin—liver cancer	9.38e-05	0.00165	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—liver cancer	9.34e-05	0.00165	CcSEcCtD
Flutamide—Rash—Epirubicin—liver cancer	9.3e-05	0.00164	CcSEcCtD
Flutamide—Dermatitis—Epirubicin—liver cancer	9.29e-05	0.00164	CcSEcCtD
Flutamide—Headache—Epirubicin—liver cancer	9.24e-05	0.00163	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—liver cancer	9.02e-05	0.00159	CcSEcCtD
Flutamide—Nausea—Epirubicin—liver cancer	8.76e-05	0.00154	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—liver cancer	8.68e-05	0.00153	CcSEcCtD
Flutamide—Rash—Doxorubicin—liver cancer	8.6e-05	0.00152	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—liver cancer	8.6e-05	0.00152	CcSEcCtD
Flutamide—Headache—Doxorubicin—liver cancer	8.55e-05	0.00151	CcSEcCtD
Flutamide—Nausea—Doxorubicin—liver cancer	8.1e-05	0.00143	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.67e-05	0.000282	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP1A1—liver cancer	2.67e-05	0.000282	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GGT1—liver cancer	2.63e-05	0.000278	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	2.63e-05	0.000278	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	2.62e-05	0.000277	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.61e-05	0.000276	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTA2—liver cancer	2.6e-05	0.000275	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	2.59e-05	0.000274	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.57e-05	0.000272	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—UGDH—liver cancer	2.56e-05	0.000271	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—SERPINE1—liver cancer	2.55e-05	0.00027	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTA1—liver cancer	2.51e-05	0.000265	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NAT2—liver cancer	2.48e-05	0.000262	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EPT1—liver cancer	2.41e-05	0.000255	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.38e-05	0.000252	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALDOB—liver cancer	2.38e-05	0.000252	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTP1—liver cancer	2.36e-05	0.00025	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	2.33e-05	0.000247	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TAT—liver cancer	2.28e-05	0.000241	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CRABP1—liver cancer	2.27e-05	0.00024	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.25e-05	0.000238	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.24e-05	0.000237	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTM1—liver cancer	2.17e-05	0.00023	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	2.14e-05	0.000227	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2.06e-05	0.000218	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.05e-05	0.000217	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.04e-05	0.000216	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	2.03e-05	0.000215	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GLUL—liver cancer	2.01e-05	0.000212	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CPT1B—liver cancer	2.01e-05	0.000212	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2e-05	0.000212	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—UGDH—liver cancer	1.99e-05	0.000211	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—HPGDS—liver cancer	1.98e-05	0.00021	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.97e-05	0.000209	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NR1H4—liver cancer	1.93e-05	0.000205	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTA3—liver cancer	1.9e-05	0.000201	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CPT1B—liver cancer	1.89e-05	0.000201	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GLUL—liver cancer	1.89e-05	0.000201	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EPT1—liver cancer	1.87e-05	0.000198	CbGpPWpGaD
Flutamide—AR—Gene Expression—H2AFX—liver cancer	1.85e-05	0.000196	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NR1H4—liver cancer	1.83e-05	0.000193	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTA3—liver cancer	1.8e-05	0.00019	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.8e-05	0.00019	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TAT—liver cancer	1.78e-05	0.000188	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.77e-05	0.000188	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSMD10—liver cancer	1.77e-05	0.000187	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSMA4—liver cancer	1.77e-05	0.000187	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	1.75e-05	0.000185	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTA4—liver cancer	1.74e-05	0.000184	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GOT2—liver cancer	1.72e-05	0.000182	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTA2—liver cancer	1.69e-05	0.000179	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.68e-05	0.000178	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARA—liver cancer	1.65e-05	0.000174	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTA4—liver cancer	1.64e-05	0.000174	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTA1—liver cancer	1.63e-05	0.000173	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NAT2—liver cancer	1.62e-05	0.000171	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP2E1—liver cancer	1.62e-05	0.000171	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—liver cancer	1.61e-05	0.000171	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTA2—liver cancer	1.6e-05	0.000169	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.56e-05	0.000166	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CPT1B—liver cancer	1.55e-05	0.000164	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GLUL—liver cancer	1.55e-05	0.000164	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALDOB—liver cancer	1.55e-05	0.000164	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTA1—liver cancer	1.54e-05	0.000163	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UGDH—liver cancer	1.54e-05	0.000163	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NAT2—liver cancer	1.53e-05	0.000162	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAPK14—liver cancer	1.52e-05	0.000161	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYCS—liver cancer	1.51e-05	0.00016	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NR1H4—liver cancer	1.49e-05	0.000158	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR1—liver cancer	1.49e-05	0.000158	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GOT1—liver cancer	1.48e-05	0.000157	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GGT1—liver cancer	1.48e-05	0.000157	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CRABP1—liver cancer	1.48e-05	0.000156	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTA3—liver cancer	1.47e-05	0.000156	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.47e-05	0.000155	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALDOB—liver cancer	1.46e-05	0.000155	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EPT1—liver cancer	1.45e-05	0.000153	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CRABP1—liver cancer	1.4e-05	0.000148	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TAT—liver cancer	1.37e-05	0.000145	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARG—liver cancer	1.36e-05	0.000144	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTA4—liver cancer	1.34e-05	0.000142	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTP1—liver cancer	1.33e-05	0.000141	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—HMOX1—liver cancer	1.31e-05	0.000139	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.31e-05	0.000139	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTA2—liver cancer	1.31e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.31e-05	0.000138	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HPGDS—liver cancer	1.29e-05	0.000137	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTA1—liver cancer	1.26e-05	0.000134	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.26e-05	0.000133	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NAT2—liver cancer	1.25e-05	0.000132	CbGpPWpGaD
Flutamide—AR—Gene Expression—SERPINE1—liver cancer	1.23e-05	0.00013	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTM1—liver cancer	1.22e-05	0.00013	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HPGDS—liver cancer	1.22e-05	0.000129	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.21e-05	0.000128	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GLUL—liver cancer	1.21e-05	0.000128	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CPT1B—liver cancer	1.21e-05	0.000128	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.2e-05	0.000127	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALDOB—liver cancer	1.2e-05	0.000127	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NR1H4—liver cancer	1.16e-05	0.000123	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP1A1—liver cancer	1.16e-05	0.000123	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSMA4—liver cancer	1.15e-05	0.000122	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSMD10—liver cancer	1.15e-05	0.000122	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA3—liver cancer	1.15e-05	0.000121	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CRABP1—liver cancer	1.14e-05	0.000121	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GOT2—liver cancer	1.12e-05	0.000119	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.11e-05	0.000117	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.09e-05	0.000116	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSMA4—liver cancer	1.09e-05	0.000115	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSMD10—liver cancer	1.09e-05	0.000115	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MTHFR—liver cancer	1.08e-05	0.000115	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARA—liver cancer	1.06e-05	0.000112	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GOT2—liver cancer	1.06e-05	0.000112	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2E1—liver cancer	1.05e-05	0.000111	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA4—liver cancer	1.05e-05	0.000111	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.03e-05	0.000109	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.02e-05	0.000108	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA2—liver cancer	1.02e-05	0.000108	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HPGDS—liver cancer	9.99e-06	0.000106	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP2E1—liver cancer	9.95e-06	0.000105	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.93e-06	0.000105	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYCS—liver cancer	9.86e-06	0.000104	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA1—liver cancer	9.85e-06	0.000104	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NAT2—liver cancer	9.74e-06	0.000103	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GOT1—liver cancer	9.67e-06	0.000102	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GGT1—liver cancer	9.67e-06	0.000102	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.64e-06	0.000102	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.54e-06	0.000101	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.36e-06	9.91e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALDOB—liver cancer	9.34e-06	9.88e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GLUL—liver cancer	9.32e-06	9.87e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CPT1B—liver cancer	9.32e-06	9.87e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYCS—liver cancer	9.31e-06	9.86e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GOT1—liver cancer	9.14e-06	9.67e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GGT1—liver cancer	9.14e-06	9.67e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—liver cancer	9.09e-06	9.63e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.05e-06	9.58e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NR1H4—liver cancer	8.99e-06	9.51e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.93e-06	9.45e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CRABP1—liver cancer	8.91e-06	9.43e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSMA4—liver cancer	8.9e-06	9.42e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSMD10—liver cancer	8.9e-06	9.42e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA3—liver cancer	8.84e-06	9.35e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARG—liver cancer	8.78e-06	9.29e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—liver cancer	8.69e-06	9.2e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GOT2—liver cancer	8.66e-06	9.17e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HMOX1—liver cancer	8.57e-06	9.07e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—liver cancer	8.21e-06	8.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2E1—liver cancer	8.14e-06	8.62e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HMOX1—liver cancer	8.09e-06	8.57e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA4—liver cancer	8.08e-06	8.56e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.02e-06	8.49e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—liver cancer	7.99e-06	8.46e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—liver cancer	7.98e-06	8.45e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—liver cancer	7.89e-06	8.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.89e-06	8.35e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA2—liver cancer	7.88e-06	8.34e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HPGDS—liver cancer	7.78e-06	8.24e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—liver cancer	7.77e-06	8.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.74e-06	8.19e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYCS—liver cancer	7.62e-06	8.07e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA1—liver cancer	7.6e-06	8.04e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1A1—liver cancer	7.57e-06	8.01e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—liver cancer	7.54e-06	7.98e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NAT2—liver cancer	7.51e-06	7.95e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GGT1—liver cancer	7.48e-06	7.91e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GOT1—liver cancer	7.48e-06	7.91e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALDOB—liver cancer	7.2e-06	7.63e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—liver cancer	7.06e-06	7.47e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.05e-06	7.46e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—liver cancer	6.97e-06	7.38e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.96e-06	7.37e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSMA4—liver cancer	6.94e-06	7.34e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSMD10—liver cancer	6.94e-06	7.34e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARA—liver cancer	6.92e-06	7.33e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CRABP1—liver cancer	6.87e-06	7.27e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GOT2—liver cancer	6.75e-06	7.14e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—liver cancer	6.72e-06	7.11e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—liver cancer	6.67e-06	7.06e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HMOX1—liver cancer	6.62e-06	7.01e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARA—liver cancer	6.54e-06	6.92e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2E1—liver cancer	6.35e-06	6.72e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—liver cancer	6.17e-06	6.53e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.14e-06	6.5e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HPGDS—liver cancer	6.01e-06	6.36e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYCS—liver cancer	5.94e-06	6.28e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—liver cancer	5.93e-06	6.27e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.87e-06	6.22e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1A1—liver cancer	5.85e-06	6.19e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GGT1—liver cancer	5.83e-06	6.17e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GOT1—liver cancer	5.83e-06	6.17e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARG—liver cancer	5.72e-06	6.06e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—liver cancer	5.6e-06	5.93e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—liver cancer	5.45e-06	5.77e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARG—liver cancer	5.41e-06	5.72e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—liver cancer	5.39e-06	5.7e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSMD10—liver cancer	5.35e-06	5.67e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSMA4—liver cancer	5.35e-06	5.67e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARA—liver cancer	5.35e-06	5.66e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—liver cancer	5.23e-06	5.54e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—liver cancer	5.21e-06	5.52e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GOT2—liver cancer	5.21e-06	5.51e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HMOX1—liver cancer	5.16e-06	5.46e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—liver cancer	5.14e-06	5.44e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—liver cancer	4.92e-06	5.21e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2E1—liver cancer	4.9e-06	5.18e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—liver cancer	4.86e-06	5.14e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—liver cancer	4.81e-06	5.09e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.81e-06	5.09e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—liver cancer	4.58e-06	4.85e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYCS—liver cancer	4.58e-06	4.85e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1A1—liver cancer	4.56e-06	4.83e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—liver cancer	4.54e-06	4.81e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GGT1—liver cancer	4.5e-06	4.76e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GOT1—liver cancer	4.5e-06	4.76e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARG—liver cancer	4.42e-06	4.68e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—liver cancer	4.29e-06	4.54e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—liver cancer	4.25e-06	4.5e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—liver cancer	4.25e-06	4.5e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARA—liver cancer	4.17e-06	4.41e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—liver cancer	4.04e-06	4.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—liver cancer	4.03e-06	4.26e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HMOX1—liver cancer	3.98e-06	4.22e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—liver cancer	3.98e-06	4.21e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.75e-06	3.96e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—liver cancer	3.71e-06	3.93e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—liver cancer	3.57e-06	3.78e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1A1—liver cancer	3.52e-06	3.72e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—liver cancer	3.51e-06	3.72e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—liver cancer	3.47e-06	3.67e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARG—liver cancer	3.45e-06	3.65e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—liver cancer	3.28e-06	3.47e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARA—liver cancer	3.22e-06	3.41e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—liver cancer	3.14e-06	3.32e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—liver cancer	3.1e-06	3.28e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—liver cancer	2.77e-06	2.93e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—liver cancer	2.76e-06	2.92e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—liver cancer	2.74e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARG—liver cancer	2.66e-06	2.82e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—liver cancer	2.62e-06	2.77e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—liver cancer	2.42e-06	2.56e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—liver cancer	2.39e-06	2.53e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—liver cancer	2.26e-06	2.39e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—liver cancer	2.14e-06	2.27e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—liver cancer	2.14e-06	2.26e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—liver cancer	2.11e-06	2.24e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—liver cancer	1.75e-06	1.85e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—liver cancer	1.67e-06	1.77e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—liver cancer	1.36e-06	1.44e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—liver cancer	1.29e-06	1.36e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—liver cancer	1.05e-06	1.11e-05	CbGpPWpGaD
